ABSTRACT
Background This study aimed to investigate and compare the applied treatments and the prognosis between patients with congenital and acquired onset cystic lymphatic malformation (cLM).
Methods This study was a retrospective cohort study in a single hospital. Patients with cLM treated at our institution were included in this study, and divided into those diagnosed in utero or at birth (CO) and those diagnosed later after birth (AO) with the acquired emerged lesion. Age, site, and size of the lesion, histological subtype, invasiveness grade of the treatment, and the treatment outcomes were compared.
Results In total, 147 patients were included. The CO group (n = 85) received more invasive treatment, with the distribution of treatment grades differing significantly from the AO group (n = 62, p = 0.005). cLMs were mainly located on the neck (n = 53, 36.1%), followed by the head and face (n = 31, 21.1%), axilla (n = 7, 4.8%), chest wall (n = 18, 12.2%), mediastinum (n = 5, 3.4%), abdominal wall (n = 4, 2.7%), retroperitoneum (n = 4, 2.7%), hip (n = 5, 3.4%), arm and hand (n = 8, 5.4%), and leg and foot (n = 12, 8.2%). No significant between-group difference was found in terms of the distribution of the main lesions (p = 0.45).
Macrocystic LM was more frequent in the AO group, with a significantly different subtype ratio (p = 0.02). The frequency of lower-grade treatment was significantly higher in the macrocystic LM subtype in the AO group (p < 0.001), and this group had a significantly higher treatment completion rate (p = 0.004). During the treatment course, improvement was seen in 72.9% and 71.0% of patients in the CO group and the AO group, respectively, indicating no significant difference (p=0.79).
Conclusions cLMs that newly appeared after birth tended to be macrocystic and had better outcomes with less-invasive treatment than congenital-onset cLMs. The timing of cLM onset could be a key prognostic factor.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by a grant from the Research Project for Intractable Diseases by the Ministry of Health, Labor, and Welfare in Japan (grant no. JPMH20FC1017 and JPMH20FC1042), received by Noriaki Usui (N.U.) and Tomoaki Taguchi (T.T.), respectively, and by a National Center for Child Health and Development grant (2021B-10), received by A.F. N.U and T.T. did not contribute to this study and are not listed as study co-authors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of the National Center for Child Health and Development (Approval No. 2021-833). Informed consent was obtained in the form of an opt-out on the website. Those who rejected were excluded.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author on reasonable request.
Abbreviations
- cLM
- Common or cystic lymphatic malformation
- LM
- Lymphatic malformation
- MRI
- Magnetic resonance imaging
- CO
- Congenital-onset
- AO
- Aquired-onset
